Main menu button

Carlsquare Equity Research interview with Biosergen

Equity Research
7 Mar 2024

Carlsquare Equity Research interview with Biosergen
Niklas Elmhammer
Niklas Elmhammer LinkedIn
Senior Equity Analyst
+46 70 898 39 59

Similar News

Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
16 Jul 2026
Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
Equity Research ALM Equity
Equity research CDON, Q2 2026: GMV leads, profits should follow
16 Jul 2026
Equity research CDON, Q2 2026: GMV leads, profits should follow
Equity Research CDON
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
15 Jul 2026
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
Equity Research CDON
Equity Research KlaraBo, Q2 2026: Income from property management is rising again
13 Jul 2026
Equity Research KlaraBo, Q2 2026: Income from property management is rising again
Equity Research KlaraBo
Equity research Zinzino: Preview Q2 2026 - Tepid growth with margin expansion
10 Jul 2026
Equity research Zinzino: Preview Q2 2026 - Tepid growth with margin expansion
Equity Research Zinzino